Annual Accounts Receivable:
N/ASummary
- ARWR annual accounts receivable is not available.
Performance
ARWR Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Quarterly Accounts Receivable:
$9.70M+$7.33M(+310.11%)Summary
- As of today, ARWR quarterly accounts receivable is $9.70 million, with the most recent change of +$7.33 million (+310.11%) on June 30, 2025.
- ARWR quarterly accounts receivable is now -86.03% below its all-time high of $69.43 million, reached on March 31, 2023.
Performance
ARWR Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ARWR Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | - | - |
| 3Y3 Years | - | +3958.2% |
| 5Y5 Years | - | -55.3% |
ARWR Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -86.0% | >+9999.0% | ||
| 5Y | 5-Year | -86.0% | >+9999.0% | ||
| All-Time | All-Time | -86.0% | >+9999.0% |
ARWR Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $9.70M(+310.1%) |
| Mar 2025 | - | $2.37M(-5.4%) |
| Dec 2024 | - | $2.50M(>+9900.0%) |
| Sep 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2023 | - | $1.25M(-98.2%) |
| Mar 2023 | - | $69.43M(+75.5%) |
| Dec 2022 | - | $39.57M(+2706.2%) |
| Sep 2022 | $1.41M(-86.3%) | $1.41M(+490.0%) |
| Jun 2022 | - | $239.00K(-81.9%) |
| Mar 2022 | - | $1.32M(+778.0%) |
| Dec 2021 | - | $150.00K(-98.5%) |
| Sep 2021 | $10.26M(+1112.6%) | $10.26M(+1428.3%) |
| Jun 2021 | - | $671.00K(-29.7%) |
| Mar 2021 | - | $955.00K(-89.4%) |
| Dec 2020 | - | $9.00M(+964.4%) |
| Sep 2020 | $845.70K(+27.9%) | $845.70K(-96.1%) |
| Jun 2020 | - | $21.69M(+1613.7%) |
| Mar 2020 | - | $1.27M(-5.9%) |
| Dec 2019 | - | $1.35M(+103.4%) |
| Sep 2019 | $661.40K(+102.0%) | $661.40K(-67.6%) |
| Jun 2019 | - | $2.04M(-84.8%) |
| Mar 2019 | - | $13.42M(+323.6%) |
| Dec 2018 | - | $3.17M(+867.8%) |
| Sep 2018 | $327.40K(+382.9%) | $327.40K(+2082.7%) |
| Jun 2018 | - | $15.00K(-8.0%) |
| Mar 2018 | - | $16.30K(-89.1%) |
| Dec 2017 | - | $149.90K(+121.1%) |
| Sep 2017 | $67.80K(-9.6%) | $67.80K(-92.8%) |
| Jun 2017 | - | $937.30K(+61.4%) |
| Mar 2017 | - | $580.80K(+868.0%) |
| Dec 2016 | - | $60.00K(-20.0%) |
| Sep 2016 | $75.00K(>+9900.0%) | $75.00K(-40.9%) |
| Dec 2014 | - | $127.00K(>+9900.0%) |
| Sep 2014 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) |
| Dec 2013 | - | $75.00K(0.0%) |
| Sep 2013 | $75.00K | $75.00K(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(-100.0%) |
| Dec 2012 | - | $2.61M(+6.2%) |
| Sep 2012 | $2.46M(+4068.9%) | $2.46M(+2.2%) |
| Jun 2012 | - | $2.40M(+0.9%) |
| Mar 2012 | - | $2.38M(-48.1%) |
| Dec 2010 | - | $4.59M(+7688.1%) |
| Sep 2010 | $58.90K(-59.1%) | $58.90K(+520.0%) |
| Jun 2010 | - | $9500.00(-93.4%) |
| Sep 2009 | $144.10K(+3414.6%) | $144.10K(-63.4%) |
| Jun 2009 | - | $393.80K(+243.3%) |
| Mar 2009 | - | $114.70K(-1.5%) |
| Dec 2008 | - | $116.40K(+2739.0%) |
| Sep 2008 | $4100.00(-98.5%) | $4100.00(-95.7%) |
| Jun 2008 | - | $94.40K(+12.5%) |
| Mar 2008 | - | $83.90K(-79.1%) |
| Dec 2007 | - | $401.00K(+46.4%) |
| Sep 2007 | $273.90K(+965.8%) | $273.90K(+72.6%) |
| Jun 2007 | - | $158.70K(+4189.2%) |
| Dec 2006 | - | $3700.00(-89.2%) |
| Jun 2006 | - | $34.40K(-14.0%) |
| Mar 2006 | - | $40.00K(+33.3%) |
| Dec 2005 | - | $30.00K(+16.7%) |
| Sep 2005 | $25.70K(-50.4%) | $25.70K(-70.4%) |
| Jun 2005 | - | $86.70K(+3234.6%) |
| Dec 2004 | - | $2600.00(-95.0%) |
| Sep 2004 | $51.80K(+8533.3%) | $51.80K(>+9900.0%) |
| Jun 2002 | - | $100.00(0.0%) |
| Mar 2002 | - | $100.00(-92.9%) |
| Dec 2001 | - | $1400.00(+133.3%) |
| Sep 2001 | $600.00(-53.8%) | $600.00(-72.7%) |
| Dec 2000 | - | $2200.00(+69.2%) |
| Sep 2000 | $1300.00(-88.5%) | $1300.00(-18.8%) |
| Jun 2000 | - | $1600.00(+6.7%) |
| Mar 2000 | - | $1500.00(+36.4%) |
| Dec 1999 | - | $1100.00 |
| Sep 1999 | $11.30K(+253.1%) | - |
| Sep 1998 | $3200.00(-69.2%) | - |
| Sep 1997 | $10.40K | - |
FAQ
- What is the all-time high annual accounts receivable for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly accounts receivable?
- What is the all-time high quarterly accounts receivable for Arrowhead Pharmaceuticals, Inc.?
What is the all-time high annual accounts receivable for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual accounts receivable is $10.26M
What is Arrowhead Pharmaceuticals, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of ARWR is $9.70M
What is the all-time high quarterly accounts receivable for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly accounts receivable is $69.43M